Skip to main content

Table 2 Cause of mortality in liver transplant recipients with donors from different age groups

From: Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database

 

Mortality within 30 days

 

Overall mortality

 
 

Group I

(Donor age =  < 34, N = 132)

Group II

(Donor age 35–49, N = 113)

Group III

(Donor age 50–64, N = 105)

Group IV

(Donor age >  = 65, N = 35)

P value

Group I

(Donor age =  < 34, N = 4723)

Group II

(Donor age 35–49, N = 3572)

Group III

(Donor age 50–64, N = 3743)

Group IV

Donor age (> = 65, N = 1238)

P value

Graft failure

15 (11.4%)

18 (15.9%)

13 (12.4%)

5 (14.3%)

0.749

61 (1.3%)

60 (1.7%)

82 (2.2%)

27 (2.2%)

0.009

Cardiovascular/cerebrovascular

45 (34.1%)

38 (33.6%)

38 (36.2%)

9 (25.7%)

0.73

128 (2.8%)

98 (2.7%)

97 (2.6%)

33 (2.7%)

0.98

Organ failure

20 (15.2%)

14 (12.4%)

13 (12.4%)

5 (14.3%)

0.906

112 (2.4%)

98 (2.7%)

109 (2.9%)

54 (4.4%)

0.002

Hemorrhage

9 (6.8%)

14 (12.4%)

10 (9.5%)

3 (8.6%)

0.521

21 (0.4%)

26 (0.7%)

19 (0.5%)

4 (0.3%)

0.224

Infection

19 (14.4%)

13 (11.5%)

16 (15.2%)

7 (20%)

0.631

72 (1.5%)

67 (1.9%)

97 (2.6%)

34 (2.7%)

0.001

HCC recurrence

0

0

0

0

N/A

157 (3.3%)

108 (3.0%)

109 (2.9%)

43 (3.5%)

0.62

Others

24 (18.2%)

16 (14.2%)

15 (14.3%)

6 (17.1%)

0.797

449 (9.5%)

358 (10.0%)

376 (10.0%)

135 (10.9%)

0.503

  1. HCC, Hepatocellular carcinoma